Spring Bank Pharmaceuticals, Inc.
Records under this name other than patents Spring Bank Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Spring Bank Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,076,303 | Nucleotide and oligonucleotide prodrugs Lapsed on the fee record Ended Dec 13, 2023 · USPTO record | Lapsed on the fee record | Ended Dec 13, 2023 | USPTO record |
| US 9,138,442 | Compositions and methods for treating viral infections Lapsed on the fee record Ended Sep 22, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | USPTO record |
| US 10,391,166 | Short oligonucleotides as vaccine adjuvants and therapeutic agents Lapsed on the fee record Ended Aug 27, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 27, 2023 | USPTO record |
| US 10,376,533 | Compositions and methods for treating viral infections Lapsed on the fee record Ended Aug 13, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 13, 2023 | USPTO record |
| US 10,344,046 | Nucleotide and oligonucleotide prodrugs Lapsed on the fee record Ended Jul 9, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 9, 2023 | USPTO record |
| US 9,040,234 | Oligonucleotide analogs as therapeutic agents Lapsed on the fee record Ended May 26, 2023 · USPTO record | Lapsed on the fee record | Ended May 26, 2023 | USPTO record |
| US 10,047,114 | Nucleotide and oligonucleotide prodrugs Lapsed on the fee record Ended Aug 14, 2022 · USPTO record | Lapsed on the fee record | Ended Aug 14, 2022 | USPTO record |
| US 8,691,787 | Nucleotide and oligonucleotide prodrugs Lapsed on the fee record Ended Apr 8, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2022 | USPTO record |
| US 8,404,651 | Compositions and methods for treating viral infections Lapsed on the fee record Ended Mar 26, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2021 | USPTO record |
| US 9,539,276 | Compositions and methods for treating viral infections Lapsed on the fee record Ended Jan 10, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 10, 2021 | USPTO record |